Posted in | News | Materials Analysis

Rigaku to Install XtaLAB Synergy-ED Electron Diffractometer at ICIQ in Spain

Rigaku, a leader in developing crystallography solutions, is proud to announce that they will be installing the first XtaLAB Synergy-ED electron diffractometer in Europe at the Institute of Chemical Research of Catalonia (ICIQ) after having won a competitive tender.

Eduardo C. Escudero-Adán and Jordi Benet-Buchholz from ICIQ (back left to right) during their visit to evaluate the XtaLAB Synergy-ED in Rigaku’s Tokyo laboratory with Sho Ito and Akihito Yamano from Rigaku (front left to right). Image credit: Rigaku.

This will be the first customer order of a dedicated electron diffractometer installed outside Japan. This instrument will play a key role in ICIQ’s research: helping to resolve crystal structures of small organic molecules, organometallic complexes, MOFs, COFs, peptides, and big supramolecular entities that are encountered in most research branches in which they are involved.

The Rigaku XtaLAB Synergy-ED is the world’s first turnkey electron diffractometer. Developed by Rigaku and JEOL, it allows crystallographers to push past the limits of single crystal XRD and even synchrotrons, allowing them to elucidate structures from crystals smaller than 50 nm in some cases.

Founded in 2000, ICIQ ranks in the top 10 research institutions in the world for chemistry. The addition of electron diffraction to their portfolio of analytical techniques will be an important enhancement that will help to improve the scientific contribution of the institution via many of its research groups. It will relieve bottlenecks in research workflows and industrial projects, where growing sufficiently sized crystals is otherwise problematic, thus, accelerating research outcomes as well as providing previously unobtainable results.

When asked about why the ICIQ team chose the Rigaku XtaLAB Synergy-ED, Dr. Eduardo C. Escudero-Adán, Manager of the Characterization Technologies Department at ICIQ, said, “We have tested the instrument in situ. The feeling was that we were in front of a well-finished equipment that fulfills our expectations in relation to the technique. One of the most outstanding points is the good integration of the software with the equipment, that allows an easy handling of the equipment by the user. It also highlights the fact of having low temperature measurement systems that have proven to be crucial for measuring sensitive samples.”.

Dr. Mark Benson, General Manager, Global Sales and Marketing for Single Crystal for Rigaku, commented, “ICIQ already has Rigaku single crystal XRD systems so the transition to electron diffraction should be fairly trivial, given both systems use the same user-inspired CrystAlisPro software for instrument control and structural determination. We look forward to further supporting ICIQ in their research endeavors and seeing publications in the near future generated using this relatively new technology.”

For more information about the XtaLAB Synergy-ED electron diffractometer, or Rigaku’s other single crystal solutions, please visit https://www.rigaku.com/products/crystallography.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Corporation. (2022, December 02). Rigaku to Install XtaLAB Synergy-ED Electron Diffractometer at ICIQ in Spain. AZoM. Retrieved on April 19, 2024 from https://www.azom.com/news.aspx?newsID=60539.

  • MLA

    Rigaku Corporation. "Rigaku to Install XtaLAB Synergy-ED Electron Diffractometer at ICIQ in Spain". AZoM. 19 April 2024. <https://www.azom.com/news.aspx?newsID=60539>.

  • Chicago

    Rigaku Corporation. "Rigaku to Install XtaLAB Synergy-ED Electron Diffractometer at ICIQ in Spain". AZoM. https://www.azom.com/news.aspx?newsID=60539. (accessed April 19, 2024).

  • Harvard

    Rigaku Corporation. 2022. Rigaku to Install XtaLAB Synergy-ED Electron Diffractometer at ICIQ in Spain. AZoM, viewed 19 April 2024, https://www.azom.com/news.aspx?newsID=60539.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.